Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of intensive insulin therapy on type 2 diabetes
ChiCTR-IPR-17010338Phase 4Recruiting
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Lispro + Metformin, Insulin Aspart + Metformin and Insulin Aspart (3 arms). Primary endpoint: blood glucose. Started Jan 2017; status: recruiting.
02
Drugs
metformininsulin lisproinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-17010338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010338.